Park Ha Biological Technology Co Ltd (BYAH) 1.44 USD (-15.29%)

Park Ha Biological Technology Co Ltd is a South Korean company specialized in the research, development, and production of biotechnology and pharmaceutical products.

Comment

Performance & Momentum

6 Months 85.30 %

1 Year 99.86 %

3 Years 99.28 %

5 Years 99.28 %

Momentum

Unlock this indicator

Recent News

Park Ha Biological Technology Co Ltd

Strategic tie-up for AI beauty-health ecosystem

6 days ago

In early June 2026, Park Ha Biological announced a strategic partnership with a subsidiary of Star Plus Legend Group to develop an AI-driven skincare and health ecosystem. The deal also aims to expand the group’s presence in healthcare, which should bolster market optimism; the +40.0% daily gain clearly reflects a very positive reaction to the announcement.

source: globenewswire.com • strategic partnership, AI

Strategic Analysis

Park Ha Biological Technology Co Ltd positions itself as a South Korean player specializing in biotechnology, focusing its efforts on the research, development, and production of innovative biological products. Its business model is built on medical innovation and the ability to integrate scientific advances to address specific therapeutic needs.

Strengths

Strong specialization in biotechnology and biological products
Recognized expertise in medical innovation and pharmaceutical research
Presence in a dynamic and growing South Korean market

Weaknesses

A very deteriorated financial performance track record over several years
No recent news flow likely to trigger a recovery

Momentum

Momentum is currently stagnant, marked by sustained underperformance over the medium and long term. This trend reflects structural difficulties, limiting the prospects for a short-term turnaround without new signs of innovation or partnerships.

Analysis performed 1 week ago